Cargando…

Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease

BACKGROUND: The SF-6D was derived from the SF-36. A single summary score is obtained allegedly preserving the descriptive richness and sensitivity to change of the SF-36 into utility measurement. We compared the SF-6D and EQ-5D on domain content, scoring distribution, pre-treatment and change scores...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Stel, Henk F, Buskens, Erik
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1475841/ https://www.ncbi.nlm.nih.gov/pubmed/16563170 http://dx.doi.org/10.1186/1477-7525-4-20

Ejemplares similares

Head-to-Head Comparison of EQ‐5D‐3L and EQ‐5D‐5L Health Values
por: Selivanova, Anna, et al.
Publicado: (2018)

Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer
por: Yousefi, Mahmood, et al.
Publicado: (2016)

A Comparison between the EQ-5D and the SF-6D in Patients with Chronic Obstructive Pulmonary Disease (COPD)
por: Chen, Jing, et al.
Publicado: (2014)

Comparison between EQ-5D and SF-6D Utility in Rural Residents of Jiangsu Province, China
por: Jin, Hui, et al.
Publicado: (2012)

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
por: Shiroiwa, Takeru, et al.
Publicado: (2015)

The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis
por: Harrison, M. J., et al.
Publicado: (2009)

Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke
por: Kim, Sang-Kyu, et al.
Publicado: (2015)

Mapping the PHQ-8 to EQ-5D, HUI3 and SF6D in patients with depression
por: Abdin, Edimansyah, et al.
Publicado: (2021)

A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain
por: Ye, Ziping, et al.
Publicado: (2019)

Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D
por: Teckle, Paulos, et al.
Publicado: (2013)

Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China
por: Zhao, Longchao, et al.
Publicado: (2019)

Comparison of the SF6D, the EQ5D, and the oswestry disability index in patients with chronic low back pain and degenerative disc disease
por: Johnsen, Lars G, et al.
Publicado: (2013)

An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand
por: Dritsaki, Melina, et al.
Publicado: (2017)

Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain
por: Barton, Garry R, et al.
Publicado: (2009)

A Comparison of EQ-5D-3L, EQ-5D-5L, and SF-6D Utilities of Patients with Musculoskeletal Disorders of Different Severity: A Health-Related Quality of Life Approach
por: Kontodimopoulos, Nikolaos, et al.
Publicado: (2022)

Comparison of the EQ-5D 3L and the SF-6D (SF-36) contemporaneous utility scores in patients with chronic kidney disease in Sri Lanka: a cross-sectional survey
por: Kularatna, Sanjeewa, et al.
Publicado: (2019)

Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients
por: Wu, Jing, et al.
Publicado: (2014)

Measuring Health Spillover Effects in Caregivers of Children with Autism Spectrum Disorder: A Comparison of the EQ-5D-3L and SF-6D
por: Brown, Clare C., et al.
Publicado: (2019)

Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey
por: Xie, Shitong, et al.
Publicado: (2022)

Comparison of the measurement properties of the EQ-5D-5L and SF-6Dv2 among overweight and obesity populations in China
por: Xie, Shitong, et al.
Publicado: (2023)

Level of agreement between patient-reported EQ-5D responses and EQ-5D responses mapped from the SF-12 in an injury population
por: Gabbe, Belinda J, et al.
Publicado: (2015)

The construct validity and responsiveness of the EQ-5D, SF-6D and Diabetes Health Profile-18 in type 2 diabetes
por: Mulhern, Brendan, et al.
Publicado: (2014)

Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis
por: Tawiah, Andrews K., et al.
Publicado: (2019)

Estimating the burden of disease in chronic pain with and without neuropathic characteristics: Does the choice between the EQ-5D and SF-6D matter?
por: Torrance, Nicola, et al.
Publicado: (2014)

Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
por: Rowen, Donna, et al.
Publicado: (2009)

Health utility measurement for people living with HIV/AIDS under combined antiretroviral therapy: A comparison of EQ-5D-5L and SF-6D
por: Wang, Xiaowen, et al.
Publicado: (2022)

Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia
por: Abdin, Edimansyah, et al.
Publicado: (2018)

The impact of different rheumatic diseases on health-related quality of life: a comparison with a selected sample of healthy individuals using SF-36 questionnaire, EQ-5D and SF-6D utility values
por: Fausto, Salaffi, et al.
Publicado: (2018)

Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain
por: Obradovic, Marko, et al.
Publicado: (2013)

Mapping of the Gastrointestinal Short Form Questionnaire (GSF-Q) into EQ-5D-3L and SF-6D in patients with gastroesophageal reflux disease
por: Monroy, Manuel, et al.
Publicado: (2018)

Estimating the disutility of relapse in relapsing–remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models
por: Ahmad, Hasnat, et al.
Publicado: (2023)

Health-related quality of life in pregnant women living with HIV: a comparison of EQ-5D and SF-12
por: Wang, Xiaowen, et al.
Publicado: (2017)

Mapping the Seattle Angina Questionnaire to EQ-5D-5L in patients with coronary heart disease
por: Li, Chaofan, et al.
Publicado: (2023)

Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis
por: Harrison, Mark J, et al.
Publicado: (2010)

Assessment of health-related quality of life in individuals with depressive symptoms: validity and responsiveness of the EQ-5D-3L and the SF-6D
por: Stolz, Maike, et al.
Publicado: (2022)

A comparison of the sensitivity of EQ-5D, SF-6D and TTO utility values to changes in vision and perceived visual function in patients with primary open-angle glaucoma
por: Bozzani, Fiammetta Maria, et al.
Publicado: (2012)

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients
por: Golicki, Dominik, et al.
Publicado: (2014)

Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis
por: Huppertz-Hauss, Gert, et al.
Publicado: (2016)

Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets
por: Mulhern, Brendan, et al.
Publicado: (2018)

Sensitivity of EQ-5D-3L, HUI2, HUI3, and SF-6D to changes in speech reception and tinnitus associated with cochlear implantation
por: Summerfield, A. Q., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m03j4hfest8gdp6aodtm1j4589